N-Methyl-d-Aspartate Receptor Encephalitis Associated With COVID-19 Infection in a Toddler

Pediatr Neurol. 2021 Jan:114:75-76. doi: 10.1016/j.pediatrneurol.2020.10.002. Epub 2020 Oct 9.

Authors

Tyler Burr¹, Christopher Barton², Elizabeth Doll², Arpita Lakhotia², Michael Sweeney³

Affiliations

¹ Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky.
² Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky; Divison of Child Neurology, Norton Children's Medical Group, Louisville, Kentucky.
³ Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky; Divison of Child Neurology, Norton Children's Medical Group, Louisville, Kentucky. Electronic address: Michael.sweeney.1@louisville.edu.

PMID: 33246132
PMCID: PMC7546658
DOI: 10.1016/j.pediatrneurol.2020.10.002

No abstract available

Keywords: Autoimmune encephalitis; COVID-19; NMDA receptor; Pediatric.

Publication types

Case Reports
Letter

MeSH terms

Anti-N-Methyl-D-Aspartate Receptor Encephalitis / diagnosis
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / etiology*
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / immunology
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / therapy
Autoantibodies / blood
Autoantibodies / cerebrospinal fluid
COVID-19 / complications*
COVID-19 / diagnosis
COVID-19 Nucleic Acid Testing
Child, Preschool
Female
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunosuppressive Agents / therapeutic use
Methylprednisolone / therapeutic use
Receptors, N-Methyl-D-Aspartate / immunology
SARS-CoV-2* / isolation & purification

Substances

Autoantibodies
Immunoglobulins, Intravenous
Immunosuppressive Agents
Receptors, N-Methyl-D-Aspartate
Methylprednisolone